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W

e sought to determine the mechanisms under
lying failure of muscle regeneration that is
observed in dystrophic muscle through hy
pothesis generation using muscle profiling data (human
dystrophy and murine regeneration). We found that trans
forming growth factor –centered networks strongly asso
ciated with pathological fibrosis and failed regeneration
were also induced during normal regeneration but at dis
tinct time points. We hypothesized that asynchronously re
generating microenvironments are an underlying driver of
fibrosis and failed regeneration. We validated this hypothe
sis using an experimental model of focal asynchronous

bouts of muscle regeneration in wild-type (WT) mice. A
chronic inflammatory state and reduced mitochondrial
oxidative capacity are observed in bouts separated by
4 d, whereas a chronic profibrotic state was seen in bouts
separated by 10 d. Treatment of asynchronously remodel
ing WT muscle with either prednisone or VBP15 mitigated
the molecular phenotype. Our asynchronous regenera
tion model for pathological fibrosis and muscle wasting
in the muscular dystrophies is likely generalizable to tissue
failure in chronic inflammatory states in other regenera
tive tissues.

Introduction
Duchenne muscular dystrophy (DMD) is a relatively common
inborn error, caused by lack of dystrophin in the membrane
cytoskeleton of muscle fibers (Hoffman et al., 1987). Myofibers
show increased plasma membrane instability and can undergo
cell death (necrosis) either individually or in groups. Necrotic
myofibers are able to regenerate within the preexisting basal
lamina through satellite cell activation, myoblast proliferation,
fusion, and maturation—a process that takes 2 wk. Robust regeneration is seen in young DMD patient muscle as well as
dystrophin-deficient dogs, mice, cats, and pigs (Chen et al., 2005;
Kornegay et al., 2012a; Klymiuk et al., 2013). Successful regeneration is associated with retained muscle function at a young
age. However, as a DMD patient ages, muscle regeneration
gradually fails, with endomysial fibrosis and fatty replacement

of the muscle. The fibrofatty infiltration is typically commensurate with muscle wasting and loss of muscle function. Some
muscles in both dystrophin-deficient DMD patients and dogs,
such as the extraocular muscles and sartorius, seem able to maintain regeneration and are functionally spared (Kornegay et al.,
2012b; Nghiem et al., 2013). Most dystrophin-deficient muscles
in cats and mice are able to successfully regenerate throughout
the normal life span (Gaschen et al., 1992). The failed regeneration
seen in the DMD muscle has features that are shared with aging
muscle, including chronic inflammatory state and loss of mitochondrial function (Baron et al., 2011). However, the age-, muscle-, and species-specific progressions from successful to failed
regeneration are poorly understood, and there has not been a
unifying model able to explain the observed transition to muscle
wasting and the loss of muscle function (Serrano et al., 2011).
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The gradual loss of muscle tissue and disorganization of
muscle structure in most muscles in a DMD patient has been
attributed, in part, to a progressive exhaustion of satellite cell
function in response to the chronic drive to repair degenerating
muscle fibers (Blau et al., 1983). However, there are conflicting
studies regarding the number and nature of muscle stem cells,
and loss of satellite cells with age is questioned as there appear
to be higher numbers of satellite cells in DMD muscle than
there are in normal muscle (Watkins and Cullen, 1986, 1988;
Maier and Bornemann, 1999; Kottlors and Kirschner, 2010).
Reports of diminished DMD myoblast proliferation have been
associated with low minimal telomere length in DMD whole
muscle (Aguennouz et al., 2011) and myoblasts (Decary et al.,
2000). However, this remains controversial as another investigation detected no overall reduction in mean telomere length in
DMD muscle cells (Oexle et al., 1997).
An alternative hypothesis promoted for failed regeneration is the excessive connective tissue proliferation (fibrosis),
a feature in common with many chronic inflammatory states
(Serrano et al., 2011). Fibrosis could impair vascularization of
muscle tissue, create an insufficient environment for effective
satellite cell proliferation and differentiation, and alter cell–cell
communication during myofiber regeneration. Histologically,
fibrosis is characterized by the exaggerated expression and
deposition of extracellular matrix components, particularly
collagen I. TGF-, a key cytokine promoting fibrosis, appears
to have a critical role in fibrosis in DMD (Chen et al., 2005;
MacDonald and Cohn, 2012) as well as most fibrotic states in
most tissues (Akhurst and Hata, 2012; Bowen et al., 2013).
Strong induction of TGF- pathways is seen in both successful
and unsuccessful remodeling (Karkampouna et al., 2012). Indeed,
TGF- is important for normal muscle regeneration, and the
molecular mechanisms underlying a change in normal versus
pathological roles of TGF- pathways have remained elusive
for muscular dystrophy and other chronic inflammatory states
(Bhattacharyya et al., 2013). The likely importance of TGF-
pathways in DMD is underscored by the recent finding of two
genetic modifiers of disease severity, both of which map to TGF-
pathways (SPP1/osteopontin [Pegoraro et al., 2011; Bello et al.,
2012]; LTPB4 [Flanigan et al., 2013]).
Here, we used a data-driven approach involving three
large mRNA profiling experiments (two human muscle biopsy
and one murine regeneration series) to generate a novel hypothesis regarding the cellular underpinnings of failed regeneration
in muscle disease (asynchronous regeneration). The hypothetical model was then tested using an experimental approach of
asynchronous bouts of staged degeneration/regeneration in
localized microenvironments of wild-type (WT) muscle.

Results
Development of bioinformatics methods
for increased sensitivity of biochemical
network selection

It is well documented that different analytical methods applied
to the same microarray dataset can provide very different interpretations of the data, often with only 30% concordance of lists
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of differentially regulated genes (Bakay et al., 2002; Seo et al.,
2004, 2006; Irizarry et al., 2005). We reasoned that increased
sensitivity for selection of differentially regulated genes could
be obtained by using multiple probe set algorithms, multiple
microarrays (e.g., U133A and U133B arrays on the same samples), and multiple queries of existing literature for biochemical
pathways (Fig. S1). Such an iterative approach would be expected to greatly increase sensitivity of gene selection but also
increase false positives. However, using an integrative approach
with a composite score of gene selection and associated networks, we could decrease false positives by focusing on the topranked composite networks (Fig. S1). In effect, as different
sources of data are assembled to derive a probability determining the specificity of a network, the most highly scored networks have considerable statistical power and significance.
To our knowledge, this two-tier composite approach has
not been previously described. This approach would be expected
to be most effective on larger and more complex datasets, and
for this reason, we used a human 12-disease group, 117-biopsy
dataset, and 234-microarray dataset as a dataset for model generation, with multiple validation and model extension datasets.

Visualization of domain knowledge identifies
a potential disease grouping by the
histological phenotype of fibrosis and
failed regeneration

Seven heat maps with clear patterns of association of disease
groups were generated and visually inspected for possible shared
pathogenesis between the clustered disease groups. Many of the
disease groupings were expected and were not studied further.
For example, juvenile dermatomyositis (JDM) is classified as
an autoimmune disorder and shows extensive inflammation
(immune cells) infiltrating the muscle (Tezak et al., 2002; Chen
et al., 2008). Indeed, a strong clustering of JDM distinct from
all other disorders was seen with both A and B chips and all
probe set algorithms, and the members of this cluster were transcripts involved in immune cell infiltration (unpublished data).
Likewise, most muscular dystrophies show some degeneration
and regeneration of myofibers, and these gene clusters were
evident as a recapitulation of embryonic developmental programs (unpublished data).
One particular grouping of the seven primary heat maps
was believed to be particularly interesting based upon domain
knowledge and was studied in some depth (Fig. 1 A). This
grouping showed a strong up-regulation of transcripts in three
disorders: DMD, JDM, and ED-D (Emery–Dreifuss muscular
dystrophy autosomal dominant; LMNA [lamin A/C] mutations).
The same cluster was up-regulated, but to a lesser extent, in Becker
muscular dystrophy (BMD; dystrophin mutation), LGMD2A
(limb girdle muscular dystrophy type 2A; CALP3 [calpain 3]
mutation), and LGMD2B (limb girdle muscular dystrophy type
2B; DYSF [dysferlin] mutation). The clustering was seen for
the A microarray and PLIER (Probe Logarithmic Intensity
Error) probe set algorithm (Fig. 1, heat map) and also all other
applied probe set algorithms (not depicted). This grouping
could be potentially significant, as these three disorders often

Figure 1. An iterative composite scoring bioinformatics approach identifies a transcript network associated with progressive muscular dystrophy.
(A) Shown is a heat map of 117 muscle biopsies grouped by diagnostic category. The individual transcripts (y axis) defining this disease clustering were
used to generate the molecular network in B. Disorders studied were facioscapulohumeral muscular dystrophy (FSH), normal human skeletal muscle (NHM),
amyotrophic lateral sclerosis (ALS), acute quadriplegic myopathy (AQM), Becker muscular dystrophy (BMD), LGMD2A (CALP3), LGMD2B (DYSF), LGMD2I
(FKRP), Emery–Dreifuss muscular dystrophy X-linked (EMRN [emerin]), Emery–Dreifuss muscular dystrophy autosomal dominant (ED-D; LMNA mutations),
juvenile dermatomyositis (JDM), and Duchenne muscular dystrophy (DMD). (B) Shown is the integration of component mRNAs from the clustering in A into
functional relationships based upon the literature (IPA). The top-ranked Ingenuity networks were merged into a 56-transcript network. This network is seen
to be centered on TGF- and fibrosis (collagens and other extracellular matrix transcripts), and the network is visualized based on the typical subcellular
localization of the encoded proteins of each transcript. Red symbols represent up-regulated transcripts, with the size of the symbol and intensity of color
scaled to the observed fold change between groups (DMD, JDM, and ED-D vs. FSH, ALS, and NHM), with fold change with the PLIER algorithm provided
under each symbol. Statistical data corresponding to this network are provided in Table 1.

show particularly severe histological patterns of fibrosis and
failed regeneration early in the disease process.
As shown in Fig. S1, this grouping was expanded to both
A and B microarrays and both PLIER and dCHIP (DNA chip
analyzer) probe set algorithms. Applying IPA (Ingenuity Pathway
Analysis) to this clustering, we found the top-ranked networks
to share many component members, and these were merged into
a 56-member network (Fig. 1 B). Fold changes were displayed
using both node size and intensity of color, with the numeric
value shown under each node. Statistical support for differential
regulation of component members is shown for the PLIER
algorithm (Table 1).
This network was centered on TGF-, a well-studied
cytokine associated with pathological fibrosis in many tissues
(Akhurst and Hata, 2012; Bowen et al., 2013) and included
many of the known components of fibrotic tissue (collagens and
lysine oxygenases). Another notable component of the network
was HIF1A (hypoxia-inducible factor 1,  subunit), a known
transcription factor strongly induced by tissue ischemia (Koh
and Powis, 2012). The nature of the network suggested that it
was simply reflective of a more severe pathology (greater fibrosis,

greater failed remodeling, and regeneration), and DMD, JDM,
and LMNA often (but not always) show more severe pathology at the initial diagnosis compared with the other disorders in
the dataset.
To test whether the network was more reflective of tissue
pathology than clinical and molecular diagnosis, a second validation dataset was generated that was then analyzed by unsupervised clustering. This new dataset contained 49 patient muscle
biopsies analyzed on HG-U133 plus 2.0 microarrays. Samples
studied were 6 normal volunteers, 17 DMD, 11 BMD, 7 LGMD2I
(limb girdle muscular dystrophy type 2I; FKRP [fukutin-related
protein deficiency]), and 8 LGMD2B.
Unsupervised clustering using the 56 network members
from Fig. 1 resulted in clustering of the 49 biopsies into two
distinct groups indicated by the dendrogram at the top (Fig. 1,
purple left group with uniform down-regulation of transcripts
and blue right group with uniform up-regulation; and Fig. 2).
The two branches did not correspond well to clinical/molecular
diagnosis, with Becker, Duchenne, FKRP-deficient and dysferlindeficient patients seen in both groups. To test whether the
segregation of groups was caused by histopathology of the
Asynchronous remodeling of muscle • Dadgar et al.
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Table 1. List of the 56 transcript genes in the TGF- network
Gene

Probe set

P-value

Fold change

ACLY

210337_s_at

0.051

1.125

ASPN

219087_at

<0.001

3.537

BGN

213905_x_at

<0.001

3.717

BMP1

207595_s_at

0.165

1.089

BNIP3L

221478_at

<0.001

1.406

CALD1

212077_at

<0.001

1.767

CAP1

200625_s_at

<0.001

2.218

CAV2

203324_s_at

<0.001

1.76

CFL1

200021_at

<0.001

1.695

CNN3

201445_at

<0.001

2.274

COL1A1

202310_s_at

<0.001

5.386

COL1A2

202404_s_at

<0.001

4.89

COL3A1

211161_s_at

<0.001

3.387

COL4A1

211981_at

<0.001

2.469

COL4A2

211966_at

<0.001

2.762

COL5A1

212489_at

<0.001

2.58

COL5A2

221729_at

<0.001

3.379

COL6A1

213428_s_at

<0.001

2.045

COL6A2

209156_s_at

<0.001

2.251

COL6A3

201438_at

<0.001

2.131

COLEC12

221019_s_at

<0.001

2.363

CSRP2

207030_s_at

<0.001

1.524

CUGBP2

202158_s_at

<0.001

1.537

CYB561

209163_at

<0.001

1.27

DAB2

201280_s_at

<0.001

2.385

ECGF1

204858_s_at

<0.001

2.037

EMILIN1

204163_at

<0.01

2.002

ENG

201809_s_at

<0.001

1.441

HIF1A

200989_at

<0.001

1.981

IFI30

201422_at

<0.001

1.886

JAG1

209098_s_at

<0.001

1.458

200699_at

<0.001

1.361

215446_s_at

<0.001

2.516

LOXL1

203570_at

<0.001

2.013

LOXL2

202998_s_at

<0.001

1.744

LTBP3

219922_s_at

<0.001

1.507

PGCP

208454_s_at

<0.01

1.237

PGRMC1

201121_s_at

<0.001

1.495

PLOD2

202620_s_at

<0.001

1.725

201215_at

<0.001

KDELR2
LOX

PLS3
RASSF1

204346_s_at

<0.05

RSU1

1.59
1.163

201980_s_at

<0.001

1.522

S100A11

200660_at

<0.001

2.888

SDC2

212158_at

0.269

1.132

SDC3

202898_at

<0.001

2.136

SDCBP

200958_s_at

<0.001

1.408

SERPINH1

207714_s_at

<0.001

1.73

SPARC

200665_s_at

<0.001

2.205

209154_at

<0.001

1.64

TBCD

211052_s_at

<0.001

1.581

TGFB1

203085_s_at

<0.001

2.626

TGFBI

201506_at

<0.001

1.852

TGFBR2

208944_at

<0.001

1.852

TGFBR3

204731_at

0.065

1.213

TPM4

209344_at

<0.001

2.086

TUBB2A

204141_at

<0.001

2.16

TAX1BP3

List of the 56 transcript genes in the TGF- network (Fig. 1 A) and their fold changes
and p-values of t test for testing the significance of their changes between two groups:
up-regulated group (DMD, JDM, and ED-D) and down-regulated group (FSH, NHM,
and ALS). The results shown were from the data processed with PLIER. Those few
transcripts showing nonsignificant p-values here are included, as they met significance
thresholds with dCHIP mismatch probe set algorithm (not depicted).
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muscle studied, the archived interpretation of the severity of
the dystrophy was accessed (all read by the same author, E.P.
Hoffman; Fig. 2, normal, mild, moderate, or severe dystrophy
groups). Mild was defined by evidence of degeneration and
regeneration but little or no fibrosis or inflammation. Moderate
showed increased inflammation and fiber size variation but
minimal or moderate fibrosis. Severe showed fibrofatty replacement of muscle and evidence of failed regeneration. Normal or
mild pathology was seen in 20/22 patients in the left branch but
only 3/27 in the right branch. In contrast, moderate or severe
pathology was seen in 2/22 patients in the left branch and 24/27
in the right branch. Thus, we concluded that this cluster and
associated networks were more reflective of severity of histological pathology than clinical/molecular diagnosis.

Query of the putative failed regeneration
network in normal staged tissue
regeneration identifies
time-resolved subnetworks

In many respects, the identification of the TGF-/fibrosis network was quite expected, as fibrosis is associated with end-stage
tissue pathology and with failed regeneration in many tissues,
including muscle. However, the majority of patient muscle biopsies were studied at initial diagnosis, before end-stage clinical disease. Moreover, there is increasing evidence that TGF-
is important for normal staged muscle regeneration (Philippou
et al., 2008; Kollias and McDermott, 2008; MacDonald and
Cohn, 2012). To query the relationship of this cluster with normal regeneration, we overlaid these network members over our
previously published 27–time point murine in vivo muscle degeneration/regeneration time series (Fig. 3; Zhao et al., 2003,
2006; Zhao and Hoffman, 2004).
All network members for which we could identify crossspecies transcript units and probe sets did indeed show significant
regulation of these transcripts in normal regeneration both by
heat map (Fig. 3 A) and by statistical comparisons (Table 2).
However, we noted from the heat map (Fig. 3 B) that different
members of this pathology-associated network were expressed at
different time points during normal regeneration. To visualize this
temporal-specific pattern, we grouped the 27–time point murine
series into four time frames corresponding to relatively distinct
periods of muscle regeneration (myoblast proliferation—days
1–3; myotube formation—days 3.5–4.5; myofiber maturation—
days 4.5–14; late-stage adaptation—days 20–40; Fig. 3 B). This
parsed the TGF- network in Fig. 1 B into a series of timeresolved subnetworks shown in Fig. 3 B, where the relative expression levels were again coded by both symbol size and color
intensity within each subnetwork. The extracellular matrix components commonly associated with pathological fibrosis were
seen in the myofiber maturation stage but not other stages.
This analysis evoked a novel hypothesis regarding the
distinction between successful regeneration and unsuccessful
remodeling (fibrosis). We reasoned that normal regeneration
is synchronous, with specific pathways and pathway members
having appropriate temporal expression patterns during the
2–3-wk muscle regeneration process. In contrast, dystrophic

Figure 2. Unsupervised (blinded) clustering of individual muscle biopsies from a 49-biopsy validation mRNA profiling dataset. Shown is a heat map using
the same 56-member TGF- network from Fig. 1 B, with visualization of unsupervised clustering of individual biopsies. The specific mRNAs are on the
y axis (not depicted), with individual patient biopsies on the x axis (diagnosis, patient number, [age at biopsy], and blinded classification of severity of the
histology [normal, mild, moderate, and severe]). The heat map shows bimodal stratification of biopsies (two branches of dendrogram at the top), with the
right branch clustering those biopsies with high levels of all or most of these transcripts, whereas the left branch shows lower levels of these transcripts. This
clustering is seen to be driven by the severity of the pathology and not patient diagnosis or age (right branch, moderate or severe dystrophic pathology;
left branch, normal or mild dystrophic pathology).

muscle was an asynchronous remodeling process, with different regions of the small muscle biopsy studied in different
stages of regeneration.
This analysis established the hypothetical model in which
asynchronous remodeling may be the driver for failed regeneration, muscle wasting, and early death in the severe dystrophies.
By this model, the complete TGF-–centered network shown in
Fig. 1 is only possible in dystrophic muscle. In normal muscle,
it is parsed into subnetworks resolved by time. We then sought
to test this model experimentally.
Establishing a model of asynchronous
muscle regeneration

We reasoned that a potential experimental model to test asynchronous regeneration would be to induce localized regions of
muscle degeneration/regeneration in WT mice, with repetitive
regional injuries in close proximity within the muscle at defined
time points. The experimental design is shown in Fig. S2. In
brief, low doses of notexin (10 µl notexin at 5 mg/µl) were injected intramuscularly along with a blue tattoo dye. At a defined
time point later, a second injection was performed with the same

low dose of notexin, using a red tattoo dye. Mice were sacrificed 13 d after the second injection, a time point when regeneration should be largely complete for both areas. We then focused
on specific areas of the muscle, where both injection sites were
separated by a relatively small area (50–300 myofibers)—the
hypothesis being that myofibers in the microenvironments immediately at the injection sites would be synchronously regenerating, whereas the myofibers in between the two injection
sites would receive regeneration cues from both sites (cross
talk microenvironment).
In an initial experiment, injections were spaced by 0
(two injections at the same time), 1, 2, 4, 5, and 10 d (four muscles
at each time point). Cryosections from the belly of each muscle
were analyzed for fibrotic content (Fig. S3 A). This analysis
showed that increasing time between injections resulted in increasing content of fibrosis of the muscle (Fig. S3 A). This suggested that the timing of injections influenced the amount of
fibrotic tissue deposited in the muscle as a whole tissue.
We hypothesized that asynchronous remodeling may result from interference in intercellular signaling when two nearby
groups of myofibers are at different stages of regeneration.
Asynchronous remodeling of muscle • Dadgar et al.
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Figure 3. The TGF- network superimposed on normal mouse muscle regeneration shows strong induction of subsets of the network at specific time frames
during regeneration. The components of the human TGF- network (Fig. 1 B) were cross-mapped to the mouse genome and queried in a 27–time point
muscle regeneration mRNA profiling dataset (Zhao et al., 2003). The top shows heat map visualization, with network members listed on the right y axis,
and the time points after regeneration are shown on the x axis (days). Each member of the TGF- network shows up-regulation within certain stages of
normal staged muscle regeneration, although these stages vary depending on the specific network member. The time points are shown grouped (colored
boxes) into early myoblast proliferation stage (blue box), myotube stage (yellow box), myofiber maturation stage (purple box), and late myofiber adaptation stage (red box). The transcripts showing up-regulation within each of these stages of regeneration were then used to generate networks (bottom). This
shows that the TGF- network seen in muscular dystrophy muscle (Fig. 1 B) is parsed into subnetworks based upon the stage of normal regeneration that
the subset of transcripts is expressed. Numbers indicate fold change. Statistical data associated with this network and heat map visualization are provided
in Table 2.
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Table 2. The subset of genes of TGF- network significantly upregulated in each of the four stages in the normal muscle regeneration
process and the t test results

Table 2. The subset of genes of TGF- network significantly upregulated in each of the four stages in the normal muscle regeneration
process and the t test results (Continued)

Gene

Gene

Probe set

P-value

S100a11

98600_at

<0.001

4.693

93017_at
94817_at
101918_at
92877_at
95542_at
95543_at
94835_f_at

<0.001
<0.05
<0.01
<0.001
<0.001
<0.001
<0.001

5.552
3.431
4.799
3.619
3.229
4.181
4.807

101080_at
103850_at

<0.01
<0.01

2.999
2.592

0.5–1 d vs.
control
Hif1a
Hif1a
Lox
Rassf1
S100a11
1–3 d vs.
control
Acly
Bgn
Bgn
Cap1
Cfl1
Cnn3
Dab2
Dab2
Dab2
Eng
Hif1a
Hif1a
Ifi30
Lox
Loxl1
Rassf1
S100a11
Sdcbp
Serpinh1
Tgfb1
Tgfbi
Tpm4
Tpm4
Tubb2a
4.5–14 d vs.
control
Bgn
Bgn
Bmp1
Cfl1
Cnn3
Col3a1
Col5a1
Col5a1
Col5a2
Col6a1
Col6a1
Col6a2
Col6a3
Csrp2
Dab2
Dab2
Eng
Hif1a
Hif1a
Ifi30
Lox
Loxl1

Probe set

98628_f_at
98629_f_at
160095_at
102379_at
98600_at

P-value

Fold change

<0.01
<0.01
<0.05
<0.01
<0.05

7.576
7.666
6.818
3.911
9.611

160207_at
162347_f_at
96049_at
93721_at
99119_at
160150_f_at
104633_at
98044_at
98045_s_at
100134_at
98628_f_at
98629_f_at
97444_at
160095_at
103850_at
102379_at
98600_at
93017_at
94817_at
101918_at
92877_at
95542_at
95543_at
94835_f_at

<0.001
<0.01
<0.01
<0.001
<0.001
<0.05
<0.01
<0.01
<0.001
<0.001
<0.001
<0.001
<0.01
<0.01
<0.001
<0.01
<0.001
<0.001
<0.01
<0.01
<0.001
<0.001
<0.001
<0.01

3.721
3.643
3.013
4.548
10.262
2.748
9.586
4.343
22.223
3.961
7.293
7.546
19.497
9.566
4.622
3.11
10.499
13.648
3.182
9.295
13.304
5.322
5.865
7.055

162347_f_at
96049_at
92701_at
99119_at
160150_f_at
102990_at
101080_at
93472_at
92567_at
162459_f_at
95493_at
93517_at
101110_at
93550_at
104633_at
98045_s_at
100134_at
98628_f_at
98629_f_at
97444_at
160095_at
103850_at

<0.001
<0.01
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.01
<0.001
<0.01
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

6.38
4.61
3.69
4.415
3.484
13.005
10.476
4.456
7.531
3.744
3.064
4.097
6.551
6.048
3.517
5.182
2.702
3.57
3.659
9.03
8.897
5.968

Sdcbp
Serpinh1
Tgfb1
Tgfbi
Tpm4
Tpm4
Tubb2a
20–40 d vs.
control
Col5a1
Loxl1

Fold change

To test this, we used laser capture microscopy (LCM) to collect
groups of myofibers at the sites of injury, as identified by red
and blue tattoo dyes, and the myofibers in between the sites
of injury. We focused on the mouse groups of 0, 4, and 10 d
between injections.
Five regions were excised using LCM from each muscle:
(1) blue dye area (injection 1; 17 d after injection for 4-d series
and 23 d after injection for 10-d series), (2) red dye area (injection 2; 13 d after injection for both series), (3) muscle fibers in
between the two injections sites (called in-between), (4) normal
nonregenerating (intact) myofibers (identified by peripheral nuclei), and (5) single regeneration site (single dye area with no
evidence of the second dye). These areas were identified by centralized nuclei myofibers located in the external area of one injury site (either blue or red).
LCM-excised regions were used for mRNA isolation and
mRNA profiling using Illumina bead arrays. Unsupervised chip
clustering showed excellent signal/noise balance, as indicated by
the clustering of microarray replicates of LCM from adjacent
muscle sections (Fig. S2 C). For data analysis, we first compared
region 4 (uninjured) versus region 5 (single regeneration). There
were very few differentially regulated transcripts, suggesting that
the muscle in region 5 had indeed successfully regenerated to
completion. Likewise, there were few statistically significant differences between region 1 (first injury) versus region 5 and region
2 (second injury) versus region 5 (single site), consistent with
successful remodeling (unpublished data).
In contrast, comparison of the tissue in-between injuries
(area 3) showed mRNA expression profiles that were quite distinct from neighboring regions and also remarkably different for
the 4-d series (Fig. 4) versus the 10-d multiinjury series (Fig. 5).
Specifically, the 4-d in-between myofiber region showed a relative loss of mitochondrial-related transcripts and an increase in
inflammatory transcripts (Fig. 4, left). The 10-d in-between myofiber region showed increase of extracellular matrix components
(Fig. 5, left). Statistical comparison of fold changes and p-values
between the 4- and 10-d multiple injection sites showed highly
significant differences, with the mitochondrial changes specific
to the 4-d time series (Table 3) and the extracellular matrix transcripts specific to the 10-d time series (Table 4). Alignment of the
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Figure 4. Muscle tissue areas located between asynchronous injuries spaced 4 d apart show chronic inflammation and loss of mitochondrial transcripts.
LCM was used to isolate regions of myofibers in between injury sites (cross talk area) spaced 4 d apart, with muscles studied 13 d after the second injection
when myofiber regeneration was expected to be largely complete. Shown is the top-ranked Ingenuity network (left) reflective of chronic inflammation (red
gene/protein symbols), and loss of mitochondrial components (green symbols). This network was then superimposed on normal murine regeneration time
series (right), separated by the mitochondrial-related transcripts (down-regulated genes; top right) and inflammatory transcripts (up-regulated genes; bottom
right). The mice that were sacrificed after regeneration should be largely complete (17 d postinjection [DPI]). However, the myofibers between the two injury
sites showed expression patterns that were more consistent with the 4-d time point (4 d postinjection). Statistical analyses associated with the heat map are
provided in Table 4. These data suggest that the myofibers in between the two injury sites are suspended in a time period of regeneration, defined by the
days between the two sequential injuries (cross talk microenvironment). Numbers indicate p-value (top) and fold change (bottom).

subcellular localizations of the components of the top-ranked Ingenuity networks for the 4 and 10 d confirmed the preponderance
of intracellular protein changes in the 4 d, in contrast to the extracellular matrix components in the 10 d (Fig. S3, B and C).
We then overlaid the gene networks in Fig. 4 over normal staged muscle regeneration, separating the up-regulated
and down-regulated transcripts (Fig. 4, right). This showed
that the down-regulated mitochondrial transcripts were highly
expressed in uninjured and fully regenerated muscle but were
strongly down-regulated both in the 4-d in-between area as
well as the 4-d time point during normal staged regeneration.
This was consistent with the myofibers in between the two injury sites having suspended regeneration at the 4-d time point.
Similarly, the up-regulated inflammatory transcripts in the inbetween area separated by 4 d were highly expressed at the 4-d
time point of normal staged regeneration but not at the later fully
regenerated time point (Fig. 4). Thus, both the down-regulated
mitochondrial transcripts and the up-regulated inflammatory
transcripts in the in-between area appeared arrested at the time
point separating the asynchronous injury times.
The 10-d staged injury series was also consistent with the
suspended development model. Connective tissue remodeling
transcripts were highly up-regulated in the in-between area separated by 10 d, and this pattern was consistent with the 10-d time
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point in normal regeneration (Fig. 5, right). Statistical analysis
showed that this pattern was largely specific to the 10-d staged
remodeling and not seen in the 4-d staged remodeling (Table 4).
The microarray data from the 10-d interval injury model
showed that the myofiber region in between asynchronous injuries showed inappropriate persistent expression of connective
tissue-remodeling transcripts, and this would be consistent with
the pathological findings of localized tissue fibrosis. Although
we had previously shown an overall increase in fibrosis that was
highest in the day 10 staged series muscle (Fig. 3 A), we refined
this analysis to the localized area in between the two injection
sites (Fig. 6). Histological visualization of the area between
the two injection sites showed dramatic fibrotic replacement of
muscle in the 10-d series, which was not seen with the 0- and
4-d series (Fig. 6).
Targeted experiments confirm aberrant
expression of fibrotic transcripts (10 d
apart) and persistent inflammation and loss
of mitochondrial capacity (4 d apart)

To validate the mRNA microarray findings, we selected specific
transcripts and proteins to evaluate using an independent series
of mice that had been subjected to the same 4- and 10-d asynchronous muscle injuries. Tattoo dyes were used to visualize the

Figure 5. Muscle tissue areas located between asynchronous injuries spaced 10 d apart show a high level expression of profibrotic gene networks. Shown
is data for the LCM region of muscle between the two injury sites spaced 10 d apart. The myofibers between the two injury sites show a high level expression of transcripts associated with connective tissue proliferation and fibrosis (top-ranked Ingenuity network, left). Superimposing this network on normal
staged murine regeneration shows that the myofibers in the area between the two injury sites show expression patterns consistent with suspension in the
10-d time point of normal regeneration. Statistical analyses associated with the heat map are provided in Table 4. Numbers indicate p-value (top) and
fold change (bottom). DPI, day postinjection.

Table 3. Down-regulated metabolic gene transcripts are shared between 3 and 4 d of synchronous regeneration and 4-d
asynchronous remodeling
Genes

P-value/FC
27–time point single regeneration series

Double injection LCM series
4 d between injections

3/4 da
ATP5A1
100753_at
COX6B1
99114_r_at
CYCS
98132_at
NDUFB5
97307_f_at
UQCRC1
101989_at
ART1
104638_at
ARL1
97505_at
MRPS12
98547_at
MRLP20
94875_at

9/10 da

13/14 da

30/40 da

10 d between injections

Single siteb

In-betweenb

Single siteb

In-betweenb

0.06

NS

NS

NS

NS

0.004/3.27

NS

NS

0.01

NS

NS

NS

NS

0.002/3.62

NS

NS

0.06

NS

NS

NS

NS

0.0002/12

NS

NS

0.002

0.05

0.05

0.04

NS

0.001/4.6

NS

0.002/2.5

0.07

NS

NS

NS

NS

0.009/2.6

NS

NS

0.02

NS

NS

NS

NS

0.00009/2.4

NS

NS

0.02

NS

NS

NS

NS

0.0005/3.5

NS

NS

0.02

NS

NS

0.04

NS

0.0006/5.4

NS

NS

0.01

NS

NS

NS

NS

0.006/3.6

NS

NS

The nine mRNA transcripts shown were significantly down-regulated in the region between asynchronous injection sites in the double LCM series when injections were
separated by 4 d, but not 10 d (8/9). In a separate 27–time point synchronous regeneration time series, these same transcripts were down-regulated at the 3–4-d
time point and not later time points. FC, fold change.
a
Days are versus 0.
b
Sites are versus nonregenerating.
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Table 4. Up-regulated fibrosis-associated gene transcripts are shared between 9 and 14 d of synchronous regeneration and 10-d asynchronous remodeling
Genes

P-value/FC
27–time point single regeneration series

Double injection LCM series
4 d between injections

3/4 da
ACTA2
93100_at
COL6A1
95493_at
COL18A1
101039_at
COL4A2
101039_at
ELN
92207_at
MMP14
160118_at
COL14A1
99476_at
COL15A1
99637_at
C2
103673_at
STAT3
99099_at
CDKNA1
94881_at
RAMP2
994444_at
ACVR2B
994444_at

9/10 da

13/14 da

0.001

0.006

0.002

0.003

0.0001

0.0001

0.00001

0.0003

NS
NS

10 d between injections

30/40 da

Single siteb

In-betweenb

Single siteb

In-betweenb

NS

NS

0.005/8.3

NS

0.008/16.8

0.02

NS

0.002/3.6

NS

0.00004/7.2

0.01

NS

NS

NS

NS

0.0001/4.0

0.01

0.008

NS

NS

NS

NS

0.0007/4.5

0.004

0.02

NS

NS

NS

NS

0.00004/3.2

0.0007

0.0002

0.006

NS

NS

NS

NS

0.0006/10.6

0.007

0.004

0.002

NS

NS

NS

NS

0.0003/1.5

0.02

NS

0.006

NS

NS

NS

NS

0.004/1.6

0.02

0.02

NS

NS

NS

NS

0.000009/2.6

0.02

0.002

0.05

NS

NS

NS

NS

0.003/4.4

0.03

0.05

0.009

NS

NS

NS

NS

0.00007/3.25

NS

0.007

0.006

NS

NS

NS

NS

0.0007/3.5

NS

0.007

0.006

NS

NS

NS

NS

0.0004/6.45

NS

The 13 gene transcripts shown were significantly up-regulated in the region between asynchronous injection sites in the double LCM series when injections were separated by 10 d, but not 4 d (0/13). In the 27–time point synchronous regeneration time series, these same transcripts showed the highest and consistent up-regulated
between 9 and14 d. FC, fold change.
a
Days are versus 0.
b
Sites are versus nonregenerating.

first and second injection sites. Tissue for quantitative RT-PCR
(qRT-PCR) was obtained by LCM. Immunohistochemistry and
enzyme histochemistry were also performed.
The 4-d interval injury model showed an increase in
inflammatory transcripts and a relative loss of mitochondrialassociated transcripts (Fig. 4). qRT-PCR confirmed the mRNA
profiling data, showing preferential loss of mitochondrial transcripts in the region in between the two injections sites, relative
to other regions of the same muscle tissue and the area between
two notexin injections made on the same day (Table 5). To
confirm the relative loss of mitochondrial oxidative capacity
predicted by expression microarray and qRT-PCR microarray
data for the 4-d in-between areas, we used standard enzyme histochemistry (NADH, cytochrome c oxidase [COX], succinate
dehydrogenase [SDH], and a combination of NADH and COX
enzymatic staining). The region between the 4-d interval injection sites showed a relative loss of mitochondrial enzymatic
activity stains compared with other injection paradigms, confirming the microarray data (Fig. S4).
To validate the up-regulation of proinflammatory transcripts, we studied three proteins by immunofluorescence localizations in three double injury mice (injuries spaced 0, 4, and
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10 d apart; CD11b, CD74, and CD163; Fig. 7). These proteins
were selected based on their role in proinflammatory pathways
as well as DMD pathogenesis. CD11b is a leukocyte marker
that induces innate immune response resulting in phagocytosis
and cell-mediated cytotoxicity (Solovjov et al., 2005). CD11b
immunostains showed the highest expression in the in-between
region at 4 d but not 10 d or the simultaneous injection control (Fig. 7 A).
Human leukocyte antigen class II histocompatibility antigen  chain (CD74) was selected because of its role in regulating adaptive immune response upon injury and its induction of
NFK- pathways (one of the earliest proinflammatory markers
of DMD; Cresswell, 1994; Chen et al., 2005). CD74 showed
mRNA up-regulation in the 4-d between area and not the 10-d
area (Fig. 4 and Table 3). Immunostaining of CD74 showed expression in the region between the 4-d injection sites but not the
region in between the 10-d injection sites (Fig. 7 B). CD74 was
also not seen in the injection sites themselves.
CD163 is a marker of specific macrophage subtypes (M2c)
in dystrophin-deficient muscles, is associated with increased
tissue repair (Villalta et al., 2009), and is a known acute phaseregulated receptor (Madsen et al., 2001). The immunostaining

Figure 6. Histological analysis of connective tissue proliferation (fibrosis). Shown is Masson’s modified trichrome staining of cryosections in the area of
muscle between injection sites staged 0, 4, and 10 d apart (n = 3 muscles per group). Endomysial fibrosis is most evident in the area between injections
space 10 d apart, consistent with the LCM expression profiling data (Fig. 4 B).

patterns for CD163, cell surface markers of monocytes and macro
phages class II (M2c), showed similar patterns (Fig. 7 C).
For the 10-d interval injuries, we had shown increases in
connective tissue by histological methods (Fig. 6 and Fig. S3 A).
To further validate this finding by immunostaining of specific
proteins, CD206 (MRC1 [mannose receptor, C type 1]; macrophage marker) and MMP9 (metalloproteinase implicated in
dystrophy pathogenesis; Dahiya et al., 2011a,b; Miyazaki et al.,
2011) were studied (Fig. 8). Both showed strong expression of
the myofiber in-between region of injuries spaced 10 d apart,
with lack of immunostaining in 4-d injuries or 0-d control.
LCM of human DMD patient muscle
shows patterns consistent with
asynchronous remodeling

Muscle biopsies from DMD patients have long been recognized
to show grouped degeneration and regeneration and focal fibrosis. This histological pattern is consistent with the asynchronous remodeling shown in our murine experimental model. To
provide evidence for asynchronous remodeling in human DMD
muscle at the molecular level, we studied a frozen diagnostic
muscle biopsy from a young child with DMD (3 yr). Frozen
sections were stained by hematoxylin and eosin to identify
neighboring regions of myofibers both within fascicles and between fascicles (Fig. 9 A), and different subregions (1–6) were
identified and then isolated by LCM and subjected to Illumina

mRNA profiling. Histochemical staining for mitochondrial
enzyme function showed the variable loss of mitochondrial oxidative phosphorylation activity typically seen in DMD biopsies
(Fig. 9 B). There were variable degrees of inflammation and
fibrosis, as detected by Masson’s trichrome and Gomori’s trichrome (Fig. 9, C and D). Unsupervised clustering of the microarrays from adjacent sections showed clear and consistent
differences in expression profiles from the six regions, with replicates of profiles clustering together, yet each region showing
a distinct pattern from other regions.
As we were unable to specifically stage the pathology of
the human biopsy, the specific timing of the degeneration and
regeneration cycles of the six regions could not be determined.
Nonetheless, the profiles were consistent with asynchronous
bouts of degeneration/regeneration leading to chronic inflammation and mitochondrial function loss associated with the murine 4-d spaced multiple injuries and the fibrosis associated with
the 10-d multiple injuries.
Pharmacogenomics of glucocorticoids
on the proposed intercellular
signaling networks

Daily glucocorticoids are considered standard of care in DMD
(Bushby et al., 2010). The mechanisms of action of glucocorticoids
in DMD are thought to be through antiinflammatory mechanisms
as in other chronic inflammatory states (Hoffman et al., 2012).

Table 5. RT-PCR validation of loss of mitochondrial transcripts in the area between staged degeneration/regeneration cycles 4 d apart
Genes

Cox6b1
Ndufs6
Ndufb5
Ndufb6

P-value/FC
Between 4D vs. single injury area

Between 4D vs. intact/uninjured area
(same section)

Between 4D vs. between area of the control
synchronous mice

0.0005/2.6
0.003/3.6
0.01/4.9
0.004/6.5

0.0004/4.9
0.04/16.0
0.002/11.0
0.009/7.2

0.004/1.4
0.001/6.9
0.02/11.0
0.0002/20.0

FC, fold change.
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Figure 7. Immunostaining of inflammatory
proteins CD11b, CD74, and CD163 shows
expression specific to intervening areas of
muscle between injuries spaced 4 d apart.
(A–C) Shown are immunofluorescence stains
for inflammatory protein markers CD11b (A),
CD74 (B), and CD163 (C). Each panel shows
matched phase contrast (marking injury sites
with tattoo dyes), antigen with nuclear stains
(DAPI), and antigen alone. All three inflammatory markers show preferential localization
in the area between the two injury sites only
when injuries are spaced 4 d apart and not
0 or 10 d apart (n = 3 muscles per group).
Arrows indicate immunoreactive material in the
microenvironment between two neighboring
sites of regeneration.

However, extensive side effect profiles, such as muscle wasting
typically associated with glucocorticoids, and differences in
response between human and mouse models have complicated
dissection of the molecular mechanism of action (Sali et al., 2012).
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Recently, we developed a novel dissociative steroid, VBP15,
that is similarly antiinflammatory yet lacks most side effects associated with glucocorticoid response element–mediated transactivation subactivities (Heier et al., 2013). We hypothesized

Figure 8. Immunostaining of proteins profibrotic markers MMP9 and CD206 shows preferential expression the area of muscle between injuries spaced
10 d apart. (A and B) Two markers associated with fibrosis, MMP9 (A) and CD206 (B), are shown by immunostaining in muscles from repeated injuries
(control = 0 d apart; 4 and 10 d apart). Both markers show preferential expression in the area in between the two injury sites when the injuries are spaced
10 d apart and not 0 (control) or 4 d (n = 3 muscle per group). Arrows indicate immunoreactive material in the microenvironment between two neighboring sites of regeneration.

that both prednisone and VBP15 might serve to suppress inappropriate intercellular signaling in the regions between asynchronously injured and remodeling areas of muscle, particularly
those associated with the proinflammatory 4-d asynchronous
cross talk regions.

We tested the effects of drug treatment on the TGF-–
based asynchronous remodeling networks both in the mdx mouse
model as well as the WT asynchronous remodeling experimental
system. For the mdx model, we obtained frozen muscle samples
from a previously described preclinical trial of prednisone and
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Figure 9. LCM of regions of a muscle biopsy from a DMD patient. (A–D) A frozen muscle biopsy from a 3-yr-old DMD patient was stained for hematoxylin
and eosin (A), mitochondrial enzyme activity (SDH; B), Masson’s modified trichrome (C), and Gomori’s modified trichrome (D). Variable states of degeneration and regeneration can be seen within each fascicle. The different regions indicated (1–6) were isolated by LCM, and individual regions (n ≥ 3 per
region) were analyzed by mRNA profiling. The areas were chosen based on visual histopathology, where both fascicles and relatively distinct histological
subareas within the fascicles were chosen. Microarray data from replicates of LCM regions microdissected from adjacent cryosections was subjected to
unsupervised chip-based clustering. This showed replicates to cluster closely in the dendrogram. This represents heterogeneity within fascicles in DMD
muscle, as hypothesized by the asynchronous regeneration model described in the accompanying text.

VBP15 (Heier et al., 2013). Drug treatments were started at
10 wk of age and continued to 26 wk of age (4 mo of treatment).
Skeletal muscles (gastrocnemius) of mice treated with 5 mg/kg/d
prednisone and 15 mg/kg/d VBP15 were tested by mRNA profiling (n = 5 per group) using Illumina bead arrays. As a baseline
study, the human TGF-–centered network, including HIF1A and
S100A11 nodes, was queried in untreated mdx versus WT mice,
and this showed strong up-regulation of the majority of network
members (22/29; Fig. 10 A). A marked exception was HIF1A,
a key ischemia-responsive gene; however, the rapid expression
of HIF1A upon necropsy may lead to postmortem expression in
WT animals. Comparing prednisone- and VBP15-treated mdx
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mice with untreated mdx mice showed both drugs to significantly
down-regulate the majority of the pathway members (15/29 prednisone and 12/29 VBP15), including TGF- ligand and HIF1A.
These data suggest that a possible mechanism of action of both
prednisone and VBP15 is through suppression of the TGF-–
related networks, leading to more successful regeneration.
We then used the same data analysis methods for the WT
asynchronous remodeling experimental system, similarly determining the effect of drug treatment on expression of the TGF-
network. As a baseline, expression profiles of LCM samples (cross
talk area vs. single injury sites) was performed for both 4- and
10-d asynchronous remodeling samples, with both showing

Figure 10. Treatment with prednisone or VBP15 suppresses the TGF- network in both WT asynchronous remodeling and mdx mice. Top images are
mRNA profile data of skeletal muscles from a 4-mo preclinical drug trial of 5 mg/kg/d prednisone and 15 mg/kg/d VBP15. Muscle functional testing and
histology on this trial has been previously published (Heier et al., 2013). The TGF- and fibrosis pathways seen in experimental asynchronous remodeling
and DMD biopsies were queried for the relative expression of mRNAs between the indicated samples, with red color indicating up-regulation (p-values
underneath network members) and green color indicating down-regulation. Untreated mdx muscle shows strong up-regulation of the network (mdx vs. WT).
Treatment with either prednisone (prednisone-treated mdx vs. untreated mdx) or VBP15 (VBP15-treated mdx vs. untreated mdx) shows strong suppression
of this network. Bottom images show comparison of expression profiles from LCM samples of asynchronously remodeling regions of WT muscle. The cross
talk region between injection sites shows up-regulation of the TGF- fibrosis network (higher in 10 d compared with 4 d) and prednisone treatment of 4-d
asynchronous remodeling mice with prednisone suppresses the network (pretreated, 4-d cross talk area vs. uninjured).

up-regulation of the TGF- network in the cross talk microenvironment (10/29 for 4 d and 16/29 for 10 d; Fig. 10). The
10-d cross talk microenvironment showed more extensive upregulation of the TGF- networks compared with 4 d, consistent with the findings presented earlier (Fig. 5). Drug treatment
of the WT 4-d asynchronous mouse model was performed 1 d
before first injury and then continuously during the 13 d after
recovery from the second injection (17 d total), using either
5 mg/kg/d prednisone or 15 mg/kg/d VBP15. LCM and mRNA
profiling of the cross talk microenvironment was compared
with single injury microenvironment in the same muscle. This
showed significant down-regulation by prednisone of TGF-
network members in the cross talk region (Fig. 10).
To validate these findings at the immunohistochemical
(protein) level, the WT 4-d asynchronous model drug-treated
muscles were immunostained for CD11b, CD74, and CD163
and compared with untreated mice. This analysis showed the
expected high expression of each protein marker in the 4-d
multiple injury sites (Fig. S5). However, daily administration of either prednisolone or VBP15 markedly reduced the

immunopositivity for these antigens (Fig. S5). These data
are consistent with both glucocorticoids and VBP15 serving
to inhibit inappropriate cross talk in asynchronously remodeling muscle.

Discussion
We used a large-scale data integration approach to query the
molecular underpinnings of progressive failure of regeneration
in the muscular dystrophies (Fig. S1). Using an initial mRNA
profiling dataset of 12 disease groups (117 biopsies and 234
microarrays), we developed an iterative composite approach to
identify clusters of transcripts that were associated with the more
severe muscle disease classes (DMD, JMD, and LMNA; Fig. 1).
Functional clustering of the diagnostic transcripts showed a 56member TGF-–centered network consistent with tissue fibrosis. Unsupervised clustering of an independent mRNA profiling
dataset of 49 biopsies from four muscle disease groups (DMD,
BMD, LGMD2I, and LGMD2B) and controls showed a strong
correlation of the TGF-–centered network with pathological
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severity rather than diagnostic criteria (Fig. 2). However, all
members of this same 56-gene TGF-–centered network were
expressed during specific stages of normal muscle regeneration, using a 27–time point staged murine regeneration dataset
(Fig. 3 A). These data analyses established the hypothesis that
normal regeneration and progressive dystrophy involved the
same proteins; the only distinction was one of timing and degree
of expression. The TGF- network was parsed into stage-specific
subnetworks in normal muscle regeneration yet occurred within
the same muscle at the same time in severely dystrophic muscle
(Fig. 3 B). We hypothesized that asynchronous bouts of degeneration and regeneration in neighboring regions of muscle tissue
could result in inappropriate cross talk between the regions.
To test this hypothesis, we developed an experimental
model for asynchronous regeneration of muscle in neighboring microenvironments. An initial injury was induced in normal mouse muscle using notexin with the injection site labeled
with tattoo dye. A second adjacent injection, labeled with a
second tattoo dye, was subsequently made, at defined times
(0–10 d). The mice were sacrificed 13 d after the second injection when regeneration would be expected to be largely complete
(Fig. S2). Then, regions of the muscle containing both injection sites and regenerating myofibers in between the sites (cross
talk microenvironment) were studied by LCM and in situ immunostaining methods. We found that increasing the time between injections led to a greater degree of abnormal collagen
deposition (fibrosis; Fig. S3), indicating that the time period between injections was an important determinant of the response
of the muscle to the damage. To better define the response of
specific subregions of asynchronously remodeling muscle, we
used LCM and mRNA profiling as well as immunostaining,
histology, and enzyme chemistry experiments. Myofibers in
between the two injury sites showed an expression pattern that
seemed suspended within the developmental stage that separated the two injections, with the 4- versus 10-d between staged
injections sharing little similarity with each other (Fig. 4 and
Fig. S3, B and C). The myofibers between the sites of the 10-d
repeat injections showed strong expression of transcripts associated with a profibrotic state, with high expression of collagens, and other connective tissue remodeling networks (Fig. 5).
This showed considerable overlap of network members, such as
TGF-, COL1A1, COL4A1, COL4A2, and COL6A1, with the
human muscle biopsy TGF- network associated with fibrosis
(Fig. 1 B) and was similar to the myotube maturation subgroup
of normal staged (synchronous) muscle regeneration (Fig. 3).
To assign statistical support to these visualizations of LCM data
networks, we took specific network members (mRNAs) and defined expression changes (p-values and fold changes) in specific
time points of regeneration, 4-d in-between LCM data and 10-d
in-between LCM data (Table 4). The expression patterns were
consistent with inappropriately prolonged and extensive connective tissue remodeling, in which signaling led to suspension
of progression through the 10-d time window of normal regeneration. In other words, the tissue region between the injection
sites staged 10 d apart remained fixed in the 9–10-d regeneration program and appeared unable to successfully mature past
this developmental time point.
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Our data showed that normal regeneration and failed regeneration involve the same networks, differences largely being
caused by the synchrony (episodic) nature of normal regeneration and the asynchronous (repeated injury) nature of failed regeneration. With failed regeneration, regenerating myofibers
are likely receiving incorrect temporal cues from their neighbors, and this inappropriate cross talk leads to inability to progress through the normal temporal stages of regeneration.
Glucocorticoids are derivatives of cortisol, the diurnal
hormone that sets day/night cycles in most animals and plants.
Pharmacological doses of glucocorticoids, typically given on a
daily basis, are considered antiinflammatory and remain among
the most effective drugs for chronic inflammatory states since
their initial use in the 1940s. There is increasing recognition of
the role of cortisol and clock genes in establishing cell cycle
regulation throughout the body and that disturbances or blunting of diurnal cortisol fluctuations are associated with the proinflammatory state (Niimi et al., 2007; Holderfield and Hughes,
2008). We recently showed that primary bronchial epithelial
cells from asthmatic patients are intrinsically dyssynchronous,
are proinflammatory, and poorly repair wounds, yet this can be
normalized with pulsed glucocorticoids (Freishtat et al., 2011;
Alcala et al., 2014).
We reasoned that the effectiveness of glucocorticoids in
DMD may be caused by resynchronization of remodeling, thereby
rescuing the inappropriate cross talk described in this paper. To
test this, we treated WT mice with prednisolone, VBP15 (a dissociative steroid), and vehicle/placebo and then tested for the drug
regimens to rescue the inappropriate cross talk in our asynchronous regeneration model. Drug treatments of both mdx mice and
the WT asynchronous model were tested (Fig. 10 and Fig. S5).
As hypothesized, both prednisolone and VBP15 reduced evidence of cross talk in both mdx and the WT asynchronous models. These data suggest that part of the mechanism of action of
both prednisone and VBP15 is through suppression of TGF-
networks induced by asynchronous remodeling.
There is an extensive literature supporting many of the findings in our study, although we believe that this study is the first
to synthesize these observations into a single model. Specifically,
transient TGF- activity is essential for maintaining normal
tissue repair and regeneration, whereas persistent TGF- activity
results in excessive fibrosis and, ultimately, scarring in skin and
internal organs. In dystrophic muscle, TGF- may affect tissue
fibrosis by elevating collagen secretion by fibroblasts and converting myoblasts to fibroblasts. Furthermore, TGF- can inhibit
terminal myogenic differentiation and thus impair muscle repair
process (Alexakis et al., 2007).
Our model may provide an explanation for the enigmatic
pathology of the mdx mouse. Dystrophin-deficient mouse muscle
shows normal histology in early weeks postpartum (0–3 wk) and
then a stage of widespread necrosis followed by relatively successful regeneration. The mdx muscle in the range of 2–12 mo
shows a mild dystrophy relative to human DMD muscle. Our
model suggests that the widespread necrotic phase (2–3 wk)
leads to well-synchronized regeneration; the severity of the initial
necrotic phase may be beneficial in that it may avoid the poorly

synchronized regeneration and pathology-associated signaling
cross talk that occurs in human DMD muscle.
The regenerative asynchrony model may be applicable
to chronic pathologies in nonmuscle tissues. Asthma involves
chronic inflammation of the airway, where pulsed glucocorticoids are standard of care. In other studies, we have shown that
normal epithelial wound repair is synchronous, that remodeling
of asthmatic cells is asynchronous and proinflammatory, and
that pulsed glucocorticoids restores regenerative synchrony and
the nonproinflammatory state (Freishtat et al., 2011; Alcala et al.,
2014). One could extend these models to chronic liver pathology, poor skin wound healing, or possibly all chronic inflammatory tissue states leading to fibrosis.

Materials and methods
Human patient muscle samples and mRNA profiles
Flash-frozen neuromuscular disease patient muscle biopsies were taken for
diagnostic purposes. Normal control biopsies were obtained from baseline
samples from exercise experiments in young adult volunteers.
Two datasets were analyzed. The first (test set) has been previously
published (Bakay et al., 2006). This set contained Affymetrix mRNA profiles
from 117 patient muscle biopsies using both HG-U133A and HG-U133B
microarrays (n = 234 microarrays total; GEO accession no. GSE3307).
The muscle disease groups were DMD (n = 10), amyotrophic lateral sclerosis (ALS; n = 9), acute quadriplegic myopathy (n = 5), BMD (n = 5), CAL
(calpain III gene mutations; LGMD2A; n = 10), DYSF (LGMD2B; n = 10),
ED-R (Emery–Dreifuss muscular dystrophy X linked; n = 4), ED-D (n = 4),
FKRP (LGMD2I; n = 7), facioscapulohumeral dystrophy (FSH; n = 14), JDM
(n = 21), and normal human skeletal muscle (NHM; n = 18). Biopsies were
taken generally at the time of diagnosis and were typically from the vastus
lateralis. The original published dataset analyzed 13 groups, but we removed the hereditary spastic paraplegia group from analyses reported here
because of a high proportion of outlier transcripts and also removed four
JDM samples that were not made public. To generate the mRNA profiles,
frozen muscle biopsies were solubilized, total RNA was isolated, RNA was
converted into biotinylated cRNA probes, hybridized to Affymetrix microarrays, and detected using fluorescent streptavidin, and microarrays were
scanned. Quality control metrics used were as previously reported (Tumor
Analysis Best Practices Working Group, 2004).
A second set of 49 human patient mRNA profiles was generated
using HG-U133 Plus 2.0 microarrays, and this dataset is new to this study.
These datasets contained profiles from 6 normal controls, 17 DMD (absence
of dystrophin), 11 BMD (present but abnormal dystrophin), 7 LGMD2I
(FKRP deficiency, a glycosylation defect), and 8 LGMD2B (DYSF). Patients
had a broad range of ages, clinical severity of their disease, and histopathological findings, although all neuromuscular disease patients showed
evidence of a dystrophic process (degeneration/regeneration of muscle
fibers). Hematoxylin and eosin stains were performed on frozen sections,
and the amount of fibrotic replacement (fibrosis) visually approximated for
by the same evaluator (E.P. Hoffman) into normal, mild, moderate, or severe fibrosis categories.
Murine muscle regeneration time series
Staged degeneration/regeneration of adult WT mice was induced by intramuscular injection of cardiotoxin into the entire gastrocnemius muscle
using a 10-needle manifold (Zhao and Hoffman, 2004). Mice were sacrificed at 27 time points after the injection, and muscles showing homogenous regeneration were selected for mRNA profiling (n = 2 per time point).
Frozen muscle samples were solubilized, total RNA was isolated, RNA was
converted to biotinylated cRNA, cRNAs were hybridized to MG-U74Av2
microarrays, and fluorescent images were scanned (GEO accession no.
GSE469). Analyses and validations of this degeneration/regeneration
time series have been previously published (Zhao et al., 2003, 2006;
Zhao and Hoffman, 2004).
Biostatistical clustering methods
We developed a novel method of defining gene clusters within a large multigroup dataset, using the 12-group human muscle biopsy dataset (Fig. S1).
Mapped image files from microarrays are interpreted using probe set

algorithms that provide probe set normalization, chip normalization, and
project normalization so that quantitative signals can be assigned to each
probe set (transcript) represented on the microarray. We and others have
shown that different probe set algorithms often lead to very different interpretations of the same microarray image files (Seo et al., 2004, 2006; Seo and
Hoffman, 2006). To avoid loss of sensitivity for gene selection by using a
single probe set algorithm, we simultaneously interpreted the muscle biopsy
data using three distinct probe set algorithms (dCHIP, MAS 5.0, and PLIER;
Fig. S1). Both A and B microarrays were used, leading to two images with
distinct probe sets representing each sample.
Two-way clustering on the rows (genes) and columns (muscular disorders) of the data matrix was performed using the VISDA (Visual Statistical Data Analyzer) software to cluster genes (Fig. S1; Wang et al., 2000,
2007; Zhu et al., 2008). Within each gene cluster, the clustering of the
muscular disorders was performed using hierarchical clustering with correlation as the similarity measure after a preprocessing step in which all samples within one muscle group were taken as an average.
This led to a series of probe set algorithm-specific gene clusters that
grouped the muscular dystrophies into larger groups based upon the specific microarray used (U133A chip or U133B chip). Thus, PA cluster i refers
to PLIER algorithm U133A chip dataset, MA cluster i refers to MAS 5.0
algorithm U133A chip dataset, and dA cluster i refers to dCHIP algorithm
U133A chip dataset (Fig. S1 and formulas in this section). Each gene cluster was then tested for gene–gene and gene–protein interactions between
cluster members using IPA. The top-ranked networks were then retained for
each cluster i (PA network i, MA network i, and dA network i; Fig. S1). We
then merged networks and assigned cumulative scores. To accomplish this,
we implemented programs to query overlaps among networks and then
derived a total score for each network based on its overlaps with all other
networks of each gene-disorder pattern. The probability for two networks,
S1 and S2 with n1 and n2 genes, respectively, having m overlapped genes
can be calculated as

p (m ) =

n −m n −m

m 1
CN
CN −mCN2−m
n

n

CN1CN2

min(n ,n2 )

∑m =0 1

, with

p (m ) = 1,

given that S1, S2, and the overlapped genes belong to the global network with N genes (N = 26,400, the total number of mammalian genes
in Ingenuity Pathway Knowledge base), and C represents a mathematical operation of combination. C of N and m gives the number of subsets
of m distinct elements of a set of N elements. Because this probability
indicates the likelihood of the overlap of the two networks occurring
randomly, log10(p(m)) may be used as a score for specifying the reliability of the overlap. In addition, the IPA dynamically computes relevant networks by focusing on the genes of interest and delivers a set of
scored networks for each gene cluster. A composite score for each network was then calculated by summing up the IPA score and the total
score based on network overlaps; the networks were ranked based on
their composite scores.
Cross-species query of time series data
Once a gene cluster of interest was selected, probe sets were tested
for recognition of canonical transcripts (e.g., 3 end of well-documented
transcript units), and then, these human transcript units were mapped to
corresponding rat and mouse transcript units using Affymetrix NetAffx
Analysis Center. The Affymetrix probe set IDs corresponding to the transcript units were then queried against the mouse time series data. All
mouse image files were analyzed using the PLIER probe set algorithm.
Candidate gene clusters were visualized in mouse datasets using heat
maps (hierarchical clustering).
All differentially regulated transcripts visualized were tested for statistical significance using t test, without correction for multiple testing. For
time series data, adjacent time points were grouped and statistically compared with a relevant control region of the time series.
Asynchronous regeneration protocol
WT BL57 mice of 4–8 wk of age were used for all asynchronous remodeling
experiments. To induce asynchronous bouts of regeneration, a 20-guage
needle was filled with 10 µl of 5-µg/ml notexin and then dipped in tattoo
dye (blue for first injection; red for second injection). Both gastrocnemii were
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surgically exposed, and the initial injection was made distally to proximally
along the axis of the muscle. The wound was closed for the number of days
indicated, and then, the second injection was performed after the time annotated in each experiment. The initial injection site could be visualized in
the muscle as a result of the tattoo dye, and the second injection was initiated
adjacent the first site. Mice were euthanized 13 d after the second injury,
and gastrocnemii were collected.
For drug treatments with 5 mg/kg/d prednisolone, 15 mg/kg/d
VBP15, or vehicle, the drug was delivered in sugar syrup orally. We had
five mice in each group. Drug treatments were started 24 h before the initial
notexin injection and then continued daily until sacrifice.
Van Gieson measures of fibrotic tissue
Reinjured muscle sections were stained by the Van Gieson method (n = 4
muscles per group). Images were taken and analyzed with ImageJ (National
Institutes of Health) to measure the extent of the connective tissue. We assayed the amount of connective tissue per field of tissue by measuring the
number of pixels occupied by red staining and then measuring the number
of pixels covered by the muscle tissue. The data are then represented as the
percentage of muscle that is collagenous connective tissue.
Laser capture microdissection
Flash-frozen muscle biopsies or specimens were sectioned at 10-µm thickness on RNase-free glass slides (CellCut; Molecular Machines & Industries,
Inc.). Slides were immediately placed in 99% ethanol to fix. Rapid hematoxylin and eosin stain using RNase-free solutions (Molecular Machines & Industries, Inc.) was then performed followed by laser capture microdissection
(CellCut Plus instrument) to identify and cut the areas of interest. We used
tubes with an adhesive cap to collect LCM-isolated regions (Molecular
Machines & Industries, Inc.).
In brief, 15 consecutive sections for mice at 4 and 10 d were subjected to LCM to isolate each region on each muscle, and cRNA amplification was performed from the combined sections. 3–4 of the 15 LCM sections
(per area per mouse) were successful in mRNA profiling, and these showed
excellent chip-based clustering. Although the LCM was performed on only
one mouse for 4 d and one mouse for 10 d (in part because of the need to
identify closely spaced tattoo dye injection sites), additional mice were used
for immunostaining validations.
LCM mRNA profiling
RNA isolation was performed using PicoPure kit (Applied Biosystems), which
includes on-column DNase digestion. Two rounds of T7-mediated cRNA amplification were performed (RiboAmp HS kit [Applied Biosystems] and then
TotalPrep-96 RNA Amplification kit [Life Technologies]). The mRNA profiling
on asynchronous mouse LCM experiments was performed in triplicate on serial sections. Murine WG-6 v2.0 Expression BeadChips (Illumina) containing 45,200 transcript probes or HumanHT-12 v4 Expression BeadChips
(Illumina) containing 47,000 transcript probes were used. Results of expression arrays were read using the HiScan SQ System (Illumina). Statistical
analyses (P ≤ 0.05 with correction for multiple testing [False Discovery Rate])
and a fold change ≤1.5 or ≥1.5) were performed to identify dysregulated
genes in the areas of interest using Partek Genomics Suite software (Partek,
Inc.). IPA was used to query protein–protein and gene–protein interactions.
TaqMan gene expression assay
The RiboAmp HS kit was used to perform two rounds of amplification on
total RNA isolated from LCM samples (n = 3 muscles per group) and convert amplified RNA to cDNA. Quantitative gene expression analysis was
performed by TaqMan-based qRT-PCR on a real-time PCR system (7900 HT
Fast; Applied Biosystems). We used TaqMan Gene Expression kits obtained
from Applied Biosystems to run qRT-PCR: Cox6b1 (Mm00824357_m1),
Ndufs6 (Mm02529639_u1), Ndufb5 (Mm00452592_m1), Ndufb6
(Mm01208591_g1), and HPRT (hypoxanthine guanine phosphoribosyltransferase; Mm01318747_g1). The expression of HPRT was analyzed as
endogenous control simultaneously, and the target gene expression in each
sample normalized to HPRT. Thermal cycling conditions were 95°C for
10 min, 50 cycles at 95°C for 15 s, and 60°C for 1 min.
Immunostaining
Monoclonal rat anti–mouse CD11b (eBioscience), mouse anti–human CD74
(Abcam), mouse anti–human macrophage surface antigen (AM-3K/CD163),
mouse anti–human mannose receptor (CD206; Abcam), and mouse anti–
human MMP9 (Santa Cruz Biotechnology, Inc.) monoclonal primary antibodies were used to perform immunofluorescence assays. The Mouse on Mouse
kit (Vector Laboratories) was used to reduce background staining when using
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mouse monoclonal antibodies on mouse tissue sections (n = 3 muscles per
group). Goat anti–mouse (Invitrogen) and goat anti–rat (Invitrogen) secondary
antibodies conjugated with Cy3 or Alexa Fluor 488 were used. Nuclei were
stained with DAPI (OCHEM). The images were acquired using a fluorescence
microscope (BX61; Olympus).
Histochemistry
NADH, SDH, COX, costaining of NADH and COX, Masson’s trichrome,
and Gomori’s modified trichrome were performed on 10-µm biopsy frozen
sections to evaluate histology and mitochondrial enzymatic activities
(Dubowitz and Sewry, 2007). Murine gastrocnemius 10-µm sections (n = 3
muscles per group) were stained following a standard Van Gieson protocol
(Dubowitz and Sewry, 2007). A minimum of nine nonoverlapping images
were analyzed in ImageJ for the percentage of connective tissue per field
of muscle tissue.
Drug treatment of mdx and WT asynchronous remodeling mice
Drug-treated mdx mice were from the previously reported preclinical trial
comparing 4 mo of 5 mg/kg/d prednisone treatment to 15 mg/kg/d
VBP15 treatment (Heier et al., 2013). Frozen archival muscle samples
were obtained for WT, mdx untreated, and the two drug-treated groups
(prednisone and VBP15). RNA was isolated, and mRNA profiling was performed using Illumina bead arrays, according to the manufacturer’s protocol
(n = 5 per group). Bioinformatics analyses were performed using TGF- pathway candidates. Drug treatment of the WT asynchronous remodeling mice
(n = 5 per group) was performed using the same drugs and treatment regimens
(5 mg/kg/d prednisone; 15 mg/kg/d VBP15), with treatment starting the
day before the first surgery until the day before euthanasia.
Microscopic image acquisition
All images were acquired using a microscope (BX61; Olympus), with U Plan
S Apochromat 20×/0.75 NA dry objective, at room temperature. Photography was performed using a camera (DP11; Olympus) with DP controller
3.2.1.276 and DP Manager 3.1.1.208 software.
Online supplemental material
Fig. S1 shows a flow chart of the data integration and biochemical network analysis on the 12-group human muscle transcriptional profiling data.
Fig. S2 shows LCM methods and chip clustering of mRNA profiles of LCM
regions of multiply injured muscle. Fig. S3 shows quantitative analysis of
endomysial fibrosis in asynchronous remodeled muscle samples. Fig. S4
shows histochemical stains for mitochondrial activity showing a relative loss
of mitochondrial oxidative phosphorylation in the area between injuries
spaced 4 d apart. Fig. S5 shows treatment of asynchronous remodeling
mouse muscle with prednisone or VBP15 suppresses the proinflammatory
proteins in between injuries spaced by 4 d. Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.201402079/DC1.
This work was supported by the US Department of Defense (W81XWH-050334), National Institutes of Health (R01 NS029525, U54 HD053177, and
R24 HD050846), Children’s National Medical Center Board of Visitors, and
the Muscular Dystrophy Association USA. The development of VBP15 is
supported by the Congressionally Directed Medical Research Programs of
the Department of Defense, Muscular Dystrophy Association Venture Philanthropy program, and the National Institutes of Health National Center for
Advancing Translational Sciences, Therapeutics for Rare and Neglected Diseases program.
Competing financial interests: E.P. Hoffman and K. Nagaraju are coinventors of patent WO 2011127048 A3 (Non-hormonal steroid modulators of
NF-B for treatment of disease), and this has been assigned to ReveraGen Biopharma. E.P. Hoffman and K. Nagaraju own founder shares of ReveraGen Biopharma and are members of the Board of Directors. The authors declare no
further competing financial interests.
Author contributions: S. Dadgar contributed to the experimental design, data
generation and interpretation, and manuscript writing. Z. Wang contributed to
the bioinformatics methods development and conduct, figures, and manuscript
writing. H. Johnston-Carey contributed to the experimental design, data generation, and writing. A. Kesari contributed to the human muscle biopsy expression profiling design and conduct. K. Nagaraju contributed to the experimental
design and data interpretation. Y.-W. Chen contributed to the human muscle
biopsy expression profiling design, conduct, and data interpretation. D.A. Hill
contributed to the immunohistochemical and histological stains and data interpretation. T. Partridge contributed to the experimental design and data interpretation. M. Giri contributed to the bioinformatics methods and data interpretation.
J. Nazarian contributed to the experimental design and data interpretation.

R. Freishtat to the contributed to the experimental design and data interpretation. J. Xuan contributed to the bioinformatics methods development. Y. Wang
contributed to the bioinformatics methods development. E.P. Hoffman contributed to the experimental design and interpretation and manuscript writing.

Submitted: 17 February 2014
Accepted: 29 August 2014

References
Aguennouz, M., G.L. Vita, S. Messina, A. Cama, N. Lanzano, A. Ciranni, C.
Rodolico, R.M. Di Giorgio, and G. Vita. 2011. Telomere shortening
is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy. Neurobiol. Aging. 32:2190–2197. http://dx.doi.org/
10.1016/j.neurobiolaging.2010.01.008
Akhurst, R.J., and A. Hata. 2012. Targeting the TGF signalling pathway in
disease. Nat. Rev. Drug Discov. 11:790–811. http://dx.doi.org/10.1038/
nrd3810
Alcala, S.E., A.S. Benton, A.M. Watson, S. Kureshi, E.M. Reeves, J. Damsker,
Z. Wang, K. Nagaraju, J. Anderson, A.M. Williams, et al. 2014. Mitotic
asynchrony induces transforming growth factor-1 secretion from airway
epithelium. Am. J. Respir. Cell Mol. Biol. 51:363–369. http://dx.doi.org/
10.1165/rcmb.2013-0396OC
Alexakis, C., T. Partridge, and G. Bou-Gharios. 2007. Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism
of collagen overproduction. Am. J. Physiol. Cell Physiol. 293:C661–
C669. http://dx.doi.org/10.1152/ajpcell.00061.2007
Bakay, M., Y.W. Chen, R. Borup, P. Zhao, K. Nagaraju, and E.P. Hoffman.
2002. Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics. 3:4. http://
dx.doi.org/10.1186/1471-2105-3-4
Bakay, M., Z. Wang, G. Melcon, L. Schiltz, J. Xuan, P. Zhao, V. Sartorelli, J.
Seo, E. Pegoraro, C. Angelini, et al. 2006. Nuclear envelope dystrophies
show a transcriptional fingerprint suggesting disruption of Rb-MyoD
pathways in muscle regeneration. Brain. 129:996–1013. http://dx.doi.org/
10.1093/brain/awl023
Baron, D., A. Magot, G. Ramstein, M. Steenman, G. Fayet, C. Chevalier, P.
Jourdon, R. Houlgatte, F. Savagner, and Y. Pereon. 2011. Immune response and mitochondrial metabolism are commonly deregulated in DMD
and aging skeletal muscle. PLoS ONE. 6:e26952. http://dx.doi.org/10
.1371/journal.pone.0026952
Bello, L., L. Piva, A. Barp, A. Taglia, E. Picillo, G. Vasco, M. Pane, S.C. Previtali,
Y. Torrente, E. Gazzerro, et al. 2012. Importance of SPP1 genotype as a
covariate in clinical trials in Duchenne muscular dystrophy. Neurology.
79:159–162. http://dx.doi.org/10.1212/WNL.0b013e31825f04ea
Bhattacharyya, S., K. Kelley, D.S. Melichian, Z. Tamaki, F. Fang, Y. Su, G.
Feng, R.M. Pope, G.R. Budinger, G.M. Mutlu, et al. 2013. Toll-like receptor 4 signaling augments transforming growth factor- responses: a novel
mechanism for maintaining and amplifying fibrosis in scleroderma. Am.
J. Pathol. 182:192–205. http://dx.doi.org/10.1016/j.ajpath.2012.09.007
Blau, H.M., C. Webster, and G.K. Pavlath. 1983. Defective myoblasts identified in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA.
80:4856–4860. http://dx.doi.org/10.1073/pnas.80.15.4856
Bowen, T., R.H. Jenkins, and D.J. Fraser. 2013. MicroRNAs, transforming
growth factor beta-1, and tissue fibrosis. J. Pathol. 229:274–285. http://
dx.doi.org/10.1002/path.4119
Bushby, K., R. Finkel, D.J. Birnkrant, L.E. Case, P.R. Clemens, L. Cripe,
A. Kaul, K. Kinnett, C. McDonald, S. Pandya, et al.; DMD Care
Considerations Working Group. 2010. Diagnosis and management of
Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological
and psychosocial management. Lancet Neurol. 9:77–93. http://dx.doi
.org/10.1016/S1474-4422(09)70271-6
Chen, Y.W., K. Nagaraju, M. Bakay, O. McIntyre, R. Rawat, R. Shi, and E.P.
Hoffman. 2005. Early onset of inflammation and later involvement of
TGFbeta in Duchenne muscular dystrophy. Neurology. 65:826–834.
http://dx.doi.org/10.1212/01.wnl.0000173836.09176.c4
Chen, Y.W., R. Shi, N. Geraci, S. Shrestha, H. Gordish-Dressman, and L.M.
Pachman. 2008. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. BMC
Immunol. 9:43. http://dx.doi.org/10.1186/1471-2172-9-43
Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules.
Annu. Rev. Immunol. 12:259–293. http://dx.doi.org/10.1146/annurev.iy.12
.040194.001355
Dahiya, S., S. Bhatnagar, S.M. Hindi, C. Jiang, P.K. Paul, S. Kuang, and A. Kumar.
2011a. Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice.
Hum. Mol. Genet. 20:4345–4359. http://dx.doi.org/10.1093/hmg/ddr362

Dahiya, S., S. Givvimani, S. Bhatnagar, N. Qipshidze, S.C. Tyagi, and A. Kumar.
2011b. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular
dystrophy. J. Immunol. 187:2723–2731. http://dx.doi.org/10.4049/jimmunol
.1101342
Decary, S., C.B. Hamida, V. Mouly, J.P. Barbet, F. Hentati, and G.S. ButlerBrowne. 2000. Shorter telomeres in dystrophic muscle consistent with
extensive regeneration in young children. Neuromuscul. Disord. 10:
113–120. http://dx.doi.org/10.1016/S0960-8966(99)00093-0
Dubowitz, V., and C.A. Sewry. 2007. Muscle Biopsy: A Practical Approach.
Third edition. Saunders Elsevier, China. 626 pp.
Flanigan, K.M., E. Ceco, K.M. Lamar, Y. Kaminoh, D.M. Dunn, J.R. Mendell,
W.M. King, A. Pestronk, J.M. Florence, K.D. Mathews, et al. United
Dystrophinopathy Project. 2013. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann. Neurol. 73:481–488.
http://dx.doi.org/10.1002/ana.23819
Freishtat, R.J., A.M. Watson, A.S. Benton, S.F. Iqbal, D.K. Pillai, M.C. Rose,
and E.P. Hoffman. 2011. Asthmatic airway epithelium is intrinsically
inflammatory and mitotically dyssynchronous. Am. J. Respir. Cell Mol.
Biol. 44:863–869. http://dx.doi.org/10.1165/rcmb.2010-0029OC
Gaschen, F.P., E.P. Hoffman, J.R. Gorospe, E.W. Uhl, D.F. Senior, G.H.
Cardinet III, and L.K. Pearce. 1992. Dystrophin deficiency causes lethal
muscle hypertrophy in cats. J. Neurol. Sci. 110:149–159. http://dx.doi
.org/10.1016/0022-510X(92)90022-D
Heier, C.R., J.M. Damsker, Q. Yu, B.C. Dillingham, T. Huynh, J.H. Van
der Meulen, A. Sali, B.K. Miller, A. Phadke, L. Scheffer, et al. 2013.
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves
muscular dystrophy without side effects. EMBO Mol. Med. 5:1569–
1585. http://dx.doi.org/10.1002/emmm.201302621
Hoffman, E.P., R.H. Brown Jr., and L.M. Kunkel. 1987. Dystrophin: the protein
product of the Duchenne muscular dystrophy locus. Cell. 51:919–928.
http://dx.doi.org/10.1016/0092-8674(87)90579-4
Hoffman, E.P., E. Reeves, J. Damsker, K. Nagaraju, J.M. McCall, E.M. Connor,
and K. Bushby. 2012. Novel approaches to corticosteroid treatment
in Duchenne muscular dystrophy. Phys. Med. Rehabil. Clin. N. Am.
23:821–828. http://dx.doi.org/10.1016/j.pmr.2012.08.003
Holderfield, M.T., and C.C. Hughes. 2008. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ. Res. 102:637–652. http://dx.doi.org/10.1161/
CIRCRESAHA.107.167171
Irizarry, R.A., D. Warren, F. Spencer, I.F. Kim, S. Biswal, B.C. Frank, E.
Gabrielson, J.G. Garcia, J. Geoghegan, G. Germino, et al. 2005. Multiplelaboratory comparison of microarray platforms. Nat. Methods. 2:345–
350. http://dx.doi.org/10.1038/nmeth756
Karkampouna, S., P. Ten Dijke, S. Dooley, and M.K. Julio. 2012. TGF signaling in liver regeneration. Curr. Pharm. Des. 18:4103–4113. http://dx.doi
.org/10.2174/138161212802430521
Klymiuk, N., A. Blutke, A. Graf, S. Krause, K. Burkhardt, A. Wuensch, S. Krebs,
B. Kessler, V. Zakhartchenko, M. Kurome, et al. 2013. Dystrophindeficient pigs provide new insights into the hierarchy of physiological
derangements of dystrophic muscle. Hum. Mol. Genet. 22:4368–4382.
http://dx.doi.org/10.1093/hmg/ddt287
Koh, M.Y., and G. Powis. 2012. Passing the baton: the HIF switch. Trends
Biochem. Sci. 37:364–372. http://dx.doi.org/10.1016/j.tibs.2012.06.004
Kollias, H.D., and J.C. McDermott. 2008. Transforming growth factor-beta and
myostatin signaling in skeletal muscle. J. Appl. Physiol. 104:579–587.
http://dx.doi.org/10.1152/japplphysiol.01091.2007
Kornegay, J.N., J.R. Bogan, D.J. Bogan, M.K. Childers, J. Li, P. Nghiem, D.A.
Detwiler, C.A. Larsen, R.W. Grange, R.K. Bhavaraju-Sanka, et al. 2012a.
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mamm. Genome. 23:85–108. http://dx.doi.org/10.1007/
s00335-011-9382-y
Kornegay, J.N., M.K. Childers, D.J. Bogan, J.R. Bogan, P. Nghiem, J. Wang, Z.
Fan, J.F. Howard Jr., S.J. Schatzberg, J.L. Dow, et al. 2012b. The paradox of muscle hypertrophy in muscular dystrophy. Phys. Med. Rehabil.
Clin. N. Am. 23:149–172. http://dx.doi.org/10.1016/j.pmr.2011.11.014
Kottlors, M., and J. Kirschner. 2010. Elevated satellite cell number in Duchenne
muscular dystrophy. Cell Tissue Res. 340:541–548. http://dx.doi.org/
10.1007/s00441-010-0976-6
MacDonald, E.M., and R.D. Cohn. 2012. TGF signaling: its role in fibrosis
formation and myopathies. Curr. Opin. Rheumatol. 24:628–634. http://
dx.doi.org/10.1097/BOR.0b013e328358df34
Madsen, M., J.H. Graversen, and S.K. Moestrup. 2001. Haptoglobin and CD163:
captor and receptor gating hemoglobin to macrophage lysosomes.
Redox Rep. 6:386–388. http://dx.doi.org/10.1179/135100001101536490
Maier, F., and A. Bornemann. 1999. Comparison of the muscle fiber diameter
and satellite cell frequency in human muscle biopsies. Muscle Nerve. 22:

Asynchronous remodeling of muscle • Dadgar et al.

157

578–583. http://dx.doi.org/10.1002/(SICI)1097-4598(199905)22:5<578::
AID-MUS5>3.0.CO;2-T
Miyazaki, D., A. Nakamura, K. Fukushima, K. Yoshida, S. Takeda, and S.
Ikeda. 2011. Matrix metalloproteinase-2 ablation in dystrophin-deficient
mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers. Hum. Mol. Genet. 20:1787–1799. http://dx.doi
.org/10.1093/hmg/ddr062
Nghiem, P.P., E.P. Hoffman, P. Mittal, K.J. Brown, S.J. Schatzberg, S.
Ghimbovschi, Z. Wang, and J.N. Kornegay. 2013. Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and
novel hypertrophy pathways in GRMD dogs. Am. J. Pathol. 183:1411–
1424. http://dx.doi.org/10.1016/j.ajpath.2013.07.013
Niimi, H., K. Pardali, M. Vanlandewijck, C.H. Heldin, and A. Moustakas. 2007.
Notch signaling is necessary for epithelial growth arrest by TGF-.
J. Cell Biol. 176:695–707. http://dx.doi.org/10.1083/jcb.200612129
Oexle, K., A. Zwirner, K. Freudenberg, A. Kohlschütter, and A. Speer. 1997.
Examination of telomere lengths in muscle tissue casts doubt on replic
ative aging as cause of progression in Duchenne muscular dystrophy.
Pediatr. Res. 42:226–231. http://dx.doi.org/10.1203/00006450-19970800000016
Pegoraro, E., E.P. Hoffman, L. Piva, B.F. Gavassini, S. Cagnin, M. Ermani, L.
Bello, G. Soraru, B. Pacchioni, M.D. Bonifati, et al.; Cooperative
International Neuromuscular Research Group. 2011. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology.
76:219–226. http://dx.doi.org/10.1212/WNL.0b013e318207afeb
Philippou, A., M. Maridaki, and M. Koutsilieris. 2008. The role of urokinasetype plasminogen activator (uPA) and transforming growth factor beta
1 (TGFbeta1) in muscle regeneration. In Vivo. 22:735–750.
Sali, A., A.D. Guerron, H. Gordish-Dressman, C.F. Spurney, M. Iantorno, E.P.
Hoffman, and K. Nagaraju. 2012. Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse.
PLoS ONE. 7:e34204. http://dx.doi.org/10.1371/journal.pone.0034204
Seo, J., and E.P. Hoffman. 2006. Probe set algorithms: is there a rational best bet?
BMC Bioinformatics. 7:395. http://dx.doi.org/10.1186/1471-2105-7-395
Seo, J., M. Bakay, Y.W. Chen, S. Hilmer, B. Shneiderman, and E.P. Hoffman.
2004. Interactively optimizing signal-to-noise ratios in expression profiling: project-specific algorithm selection and detection p-value weighting
in Affymetrix microarrays. Bioinformatics. 20:2534–2544. http://dx.doi
.org/10.1093/bioinformatics/bth280
Seo, J., H. Gordish-Dressman, and E.P. Hoffman. 2006. An interactive power analysis tool for microarray hypothesis testing and generation. Bioinformatics.
22:808–814. http://dx.doi.org/10.1093/bioinformatics/btk052
Serrano, A.L., C.J. Mann, B. Vidal, E. Ardite, E. Perdiguero, and P. MuñozCánoves. 2011. Cellular and molecular mechanisms regulating fibrosis
in skeletal muscle repair and disease. Curr. Top. Dev. Biol. 96:167–201.
http://dx.doi.org/10.1016/B978-0-12-385940-2.00007-3
Solovjov, D.A., E. Pluskota, and E.F. Plow. 2005. Distinct roles for the a and
b subunits in the functions of integrin aMb2. J. Biol. Chem. 280:1336–
1345. http://dx.doi.org/10.1074/jbc.M406968200
Tezak, Z., E.P. Hoffman, J.L. Lutz, T.O. Fedczyna, D. Stephan, E.G. Bremer,
I. Krasnoselska-Riz, A. Kumar, and L.M. Pachman. 2002. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis:
a novel model of pathogenesis. J. Immunol. 168:4154–4163. http://dx.doi
.org/10.4049/jimmunol.168.8.4154
Tumor Analysis Best Practices Working Group. 2004. Expression profiling—
best practices for data generation and interpretation in clinical trials. Nat.
Rev. Genet. 5:229–237. http://dx.doi.org/10.1038/nrg1297
Villalta, S.A., H.X. Nguyen, B. Deng, T. Gotoh, and J.G. Tidball. 2009. Shifts
in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.
Hum. Mol. Genet. 18:482–496. http://dx.doi.org/10.1093/hmg/ddn376
Wang, J., H. Li, Y. Zhu, M. Yousef, M. Nebozhyn, M. Showe, L. Showe, J.
Xuan, R. Clarke, and Y. Wang. 2007. VISDA: an open-source caBIG
analytical tool for data clustering and beyond. Bioinformatics. 23:2024–
2027. http://dx.doi.org/10.1093/bioinformatics/btm290
Wang, Y., L. Luo, M.T. Freedman, and S.Y. Kung. 2000. Probabilistic principal component subspaces: a hierarchical finite mixture model for data
visualization. IEEE Trans. Neural Netw. 11:625–636. http://dx.doi.org/10
.1109/72.846734
Watkins, S.C., and M.J. Cullen. 1986. A quantitative comparison of satellite
cell ultrastructure in Duchenne muscular dystrophy, polymyositis, and
normal controls. Muscle Nerve. 9:724–730. http://dx.doi.org/10.1002/
mus.880090808
Watkins, S.C., and M.J. Cullen. 1988. A quantitative study of myonuclear and
satellite cell nuclear size in Duchenne’s muscular dystrophy, polymyositis and normal human skeletal muscle. Anat. Rec. 222:6–11. http://dx.doi
.org/10.1002/ar.1092220103



158

JCB • VOLUME 207 • NUMBER 1 • 2014

Zhao, P., and E.P. Hoffman. 2004. Embryonic myogenesis pathways in muscle
regeneration. Dev. Dyn. 229:380–392. http://dx.doi.org/10.1002/dvdy
.10457
Zhao, P., J. Seo, Z. Wang, Y. Wang, B. Shneiderman, and E.P. Hoffman. 2003.
In vivo filtering of in vitro expression data reveals MyoD targets. C. R.
Biol. 326:1049–1065. http://dx.doi.org/10.1016/j.crvi.2003.09.035
Zhao, P., G. Caretti, S. Mitchell, W.L. McKeehan, A.L. Boskey, L.M. Pachman,
V. Sartorelli, and E.P. Hoffman. 2006. Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4
transcriptional pathway. J. Biol. Chem. 281:429–438. http://dx.doi.org/
10.1074/jbc.M507440200
Zhu, Y., H. Li, D.J. Miller, Z. Wang, J. Xuan, R. Clarke, E.P. Hoffman, and
Y. Wang. 2008. caBIG VISDA: modeling, visualization, and discovery
for cluster analysis of genomic data. BMC Bioinformatics. 9:383. http://
dx.doi.org/10.1186/1471-2105-9-383

